Your browser doesn't support javascript.
loading
Metabolic modelling-based in silico drug target prediction identifies six novel repurposable drugs for melanoma.
Bintener, Tamara; Pacheco, Maria Pires; Philippidou, Demetra; Margue, Christiane; Kishk, Ali; Del Mistro, Greta; Di Leo, Luca; Moscardó Garcia, Maria; Halder, Rashi; Sinkkonen, Lasse; De Zio, Daniela; Kreis, Stephanie; Kulms, Dagmar; Sauter, Thomas.
Afiliação
  • Bintener T; Department of Life Sciences and Medicine, University of Luxembourg, Belvaux, Luxembourg.
  • Pacheco MP; Department of Life Sciences and Medicine, University of Luxembourg, Belvaux, Luxembourg.
  • Philippidou D; Department of Life Sciences and Medicine, University of Luxembourg, Belvaux, Luxembourg.
  • Margue C; Department of Life Sciences and Medicine, University of Luxembourg, Belvaux, Luxembourg.
  • Kishk A; Department of Life Sciences and Medicine, University of Luxembourg, Belvaux, Luxembourg.
  • Del Mistro G; Experimental Dermatology, Department of Dermatology, TU-Dresden, Dresden, Germany.
  • Di Leo L; National Center for Tumour Diseases, TU-Dresden, Dresden, Germany.
  • Moscardó Garcia M; Melanoma Research Team, Danish Cancer Society Research Center, Copenhagen, Denmark.
  • Halder R; Department of Life Sciences and Medicine, University of Luxembourg, Belvaux, Luxembourg.
  • Sinkkonen L; Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Belvaux, Luxembourg.
  • De Zio D; Department of Life Sciences and Medicine, University of Luxembourg, Belvaux, Luxembourg.
  • Kreis S; Melanoma Research Team, Danish Cancer Society Research Center, Copenhagen, Denmark.
  • Kulms D; Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Sauter T; Department of Life Sciences and Medicine, University of Luxembourg, Belvaux, Luxembourg.
Cell Death Dis ; 14(7): 468, 2023 07 26.
Article em En | MEDLINE | ID: mdl-37495601

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Proto-Oncogênicas B-raf / Melanoma Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Cell Death Dis Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Proto-Oncogênicas B-raf / Melanoma Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Cell Death Dis Ano de publicação: 2023 Tipo de documento: Article